Loading...
Laboratory Corporation of America Holdings
LH•NYSE
Healthcare
Medical - Equipment & Services
$261.10
$-0.55(-0.21%)
Laboratory Corporation of America Holdings (LH) Financial Performance & Statements
Review Laboratory Corporation of America Holdings’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.97%
↑ 6.97%
Operating Income Growth
52.40%
↑ 52.40%
Net Income Growth
78.47%
↑ 78.47%
Operating Cash Flow Growth
19.44%
↑ 19.44%
Operating Margin
8.37%
↑ 8.37%
Gross Margin
27.42%
↑ 27.42%
Net Profit Margin
5.55%
↑ 5.55%
ROE
8.98%
↑ 8.98%
ROIC
7.10%
↑ 7.10%
Laboratory Corporation of America Holdings (LH) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Laboratory Corporation of America Holdings stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|
| Revenue | $3.35B | $3.33B | $3.28B |
| Cost of Revenue | $2.40B | $2.43B | $2.38B |
| Gross Profit | $948.00M | $896.30M | $904.40M |
| Gross Profit Ratio | $0.28 | $0.27 | $0.28 |
| R&D Expenses | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $546.00M | $595.20M | $568.60M |
| Operating Expenses | $546.00M | $679.80M | $650.30M |
| Total Costs & Expenses | $2.94B | $3.11B | $3.03B |
| Interest Income | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$56.00M | $63.40M | $50.40M |
| Depreciation & Amortization | $0.00 | $170.60M | $161.50M |
| EBITDA | $326.00M | $417.80M | $422.50M |
| EBITDA Ratio | $0.10 | $0.13 | $0.13 |
| Operating Income | $326.00M | $216.50M | $254.10M |
| Operating Income Ratio | $0.10 | $0.07 | $0.08 |
| Other Income/Expenses (Net) | -$50.80M | -$32.70M | -$43.50M |
| Income Before Tax | $275.20M | $183.80M | $210.60M |
| Income Before Tax Ratio | $0.08 | $0.06 | $0.06 |
| Income Tax Expense | $62.20M | $40.20M | $41.00M |
| Net Income | $212.80M | $143.40M | $169.30M |
| Net Income Ratio | $0.06 | $0.04 | $0.05 |
| EPS | $2.54 | $1.72 | $2.02 |
| Diluted EPS | $2.52 | $1.70 | $2.01 |
| Weighted Avg Shares Outstanding | $83.60M | $83.60M | $84.00M |
| Weighted Avg Shares Outstanding (Diluted) | $84.30M | $84.20M | $84.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan